# Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Source: https://onco.cc/trials/nct03965234/  
OnCo record `nct03965234` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of cisplatin in colorectal cancer, run by Roswell Park Cancer Institute, now recruiting.

## Summary

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases is a phase 1/2, interventional study registered as NCT03965234 by Roswell Park Cancer Institute, with a registry enrolment figure of 99 participants, started 2020-07-16 and due to reach its primary completion in 2029-05-25. Interventions recorded: Cisplatin; Isolated Chemotherapeutic Lung Perfusion; Metastasectomy. Conditions listed: Metastatic Bone Sarcoma; Metastatic Malignant Neoplasm in the Lung; Metastatic Soft Tissue Sarcoma; Metastatic Unresectable Sarcoma; Resectable Sarcoma; Colorectal Cancer. Primary outcome: Incidence of local toxicities (Phase I); Recommended phase II dose (Phase I); Local recurrence (Phase II). Colorectal eligibility wording from the registry: "* Colorectal carcinoma". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT03965234
- Phase: 1/2
- Setting: Phase I/ II Study of Pulmonary Suffusion to Control Minimal Residual Disease in Resectable or Ablatable Sarcoma or Colorectal Pulmonary Metastases
- Sponsor: Roswell Park Cancer Institute
- Enrolled: 99

## Sources

- ClinicalTrials.gov NCT03965234: https://clinicaltrials.gov/study/NCT03965234

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [MRD / molecular residual disease testing](https://onco.cc/technologies/mrd-testing/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Cisplatin](https://onco.cc/drugs/cisplatin/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct03965234.json